Both types of insole were worn inside the shoes daily for 12 months.1 Participants were recruited from the community if they were aged 50 years or over and had a clinical and radiographic diagnosis of mild to moderately severe medial knee osteoarthritis. In total, 103 individuals were randomised...
Citeline®, an Informa business unit, and the pharmaceutical industry's leading research authority on clinical trials, reported today that clinical trial transparency, also known as responsible data sharing, is in a much healthier state than shown in previous studies, when you refer to the right...
Publication bias in clinical trials of electronic health records. J Biomed Inform. 2013;46:139-41.David K. Vawdrey, George Hripcsak,‖ Publication bias in clinical trials of electronic health records‖, Journal of Biomedical Informatics, Elsevier, Sep 2012....
Pharma has a great opportunity ahead of it when it comes to conducting representative clinical trials. The industry’s application of mRNA techniques during the pandemic led to the fastest vaccine development in history. The processes used are now seeing
In cohort studies, knowledge of exposures of interest should be kept separate from screening, identification and recording of relevant outcomes of interest. In clinical trials, allocation concealment and blinding of all study staff are critical to maintaining a low risk of bias throughout the trial....
ObjectiveTo develop and evaluate RobotReviewer, a machine learning (ML) system that automatically assesses bias in clinical trials. From a (PDF-formatted) trial report, the system should determine risks of bias for the domains defined by the Cochrane Risk of Bias (RoB) tool, and extract support...
Industry-Sponsored Clinical Research over the past 2 decades, the pharmaceutical industry has gained unprecedented control over the evaluation of its own products. drug companies now finance m... Angell,Marcia - 《Jama》 被引量: 0发表: 2008年 Industry bias in clinical trials The conclusion here ...
Clinical trials are the primary means to evaluate the efficacy and safety of new drugs and other medical technologies. When published in peer-reviewed
Without the totality of evidence, clinical practice may be misguided. The objective of this work was to examine the extent of reporting bias in clinical trials of breast reconstruction surgery. Methods: We searched and extracted data from all completed breast reconstruction clinical trials published ...
Bias in treatment assignment in controlled clinical trials. Controlled clinical trials of the treatment of acute myocardial infarction offer a unique opportunity for the study of the potential influence on outcome o... T Chalmers,P Celano,H Sacks,... - 《New England Journal of Medicine》 被引量...